Description
Uridine Monophosphate Disodium Powder
| Uridine Monophosphate Disodium | |
| CAS Number | 9858-97-9 |
| Molar Mass | 324,1813g/mol-1 |
| Chemical Formula | C9H13N2O9P |
| IUPAC Name | [(2R,3S,4R,5R)-5-(2,4-Dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate |
Introduction
Uridine Monophosphate Disodium, a prominent compound in nucleic acid metabolism, emerges as a focal point in neurological research. Recognized for its involvement in various cellular processes, this research product is at the forefront of investigations exploring its potential benefits in learning, memory, brain health, sleep modulation, and fat mass regulation.
Key Characteristics
Uridine Monophosphate Disodium is a nucleotide derivative crucial for RNA synthesis and the formation of cell membranes. It is notable for its role in enhancing cognitive function and cellular processes related to brain health.
Research Applications
Researchers are actively exploring the diverse applications of Uridine Monophosphate Disodium in neuroscience. Its involvement in fundamental cellular mechanisms makes it a subject of interest for studies related to cognition, sleep modulation, and metabolic processes.
Research Benefits
Uridine Monophosphate on Learning, Memory, and Brain Health
Studies suggest that Uridine Monophosphate may have positive effects on learning and memory processes. Its involvement in synaptic formation and neurotransmitter regulation positions it as a potential contributor to overall brain health.
Uridine Monophosphate on Sleep
Research indicates a potential link between Uridine Monophosphate and sleep modulation. Investigations are underway to understand its impact on sleep architecture and the regulatory mechanisms involved in promoting restful sleep.
Uridine Monophosphate on Fat Mass Research
Preliminary studies suggest a connection between Uridine Monophosphate and fat mass regulation. Researchers are exploring its potential role in metabolic processes and its impact on body composition.
Summary
Uridine Monophosphate Disodium, a vital player in cellular processes, holds promise in various research applications. With potential benefits spanning cognitive function, sleep modulation, and metabolic regulation, Uridine Monophosphate Disodium presents a compelling avenue for further investigation in the realm of neuroscience.
Disclaimer
This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.
Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).
Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.
Upon the finalization of your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. Should you find any dissatisfaction with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].
IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.
References
- Holguin S, Martinez J, Chow C, Wurtman R. Dietary uridine enhances the improvement in learning and memory produced by administering DHA to gerbils. FASEB J. 2008 Nov;22(11):3938-46. doi: 10.1096/fj.08-112425. Epub 2008 Jul 7. PMID: 18606862; PMCID: PMC2574024. [Read More].
- Ocalan B, Cakir A, Koc C, Suyen GG, Kahveci N. Uridine treatment prevents REM sleep deprivation-induced learning and memory impairment. Neurosci Res. 2019 Nov;148:42-48. doi: 10.1016/j.neures.2019.01.003. Epub 2019 Jan 24. PMID: 30685492. [Read More].
- McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA; AIDS Clinical Trials Group A5229 Team. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS. 2010 Oct 23;24(16):2507-15. doi: 10.1097/QAD.0b013e32833ea9bc. PMID: 20827170; PMCID: PMC2956768. [Read More].
Reviews
There are no reviews yet.